SOCS3 was found to limit inflammation-associated oncogenic transformation in the colon, via regulation of STAT3 and NFκB [283], while in ulcerative colitis, loss of SOCS3 expression was observed in the areas of colonic dysplasia [284]. This evidence concerns the gene SOCS3 and ulcerative colitis.